Short Interest in Reckitt Benckiser Group PLC (OTCMKTS:RBGLY) Drops By 40.1%

Key Points

• Reckitt Benckiser Group saw a substantial 40.1% decrease in short interest from August 15th to August 31st, with total short shares dropping to 287,200.
• The company announced a dividend payment of $0.2106, payable on September 25th, representing a yield of 341.0%.
• Analyst ratings for Reckitt Benckiser Group are positive, with a consensus rating of "Buy", and several analysts upgrading their ratings for the stock recently.

Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) was the recipient of a large drop in short interest in August. As of August 31st, there was short interest totaling 287,200 shares, a drop of 40.1% from the August 15th total of 479,400 shares. Based on an average trading volume of 439,400 shares, the short-interest ratio is presently 0.7 days. Approximately 0.0% of the shares of the stock are short sold. Approximately 0.0% of the shares of the stock are short sold. Based on an average trading volume of 439,400 shares, the short-interest ratio is presently 0.7 days.

Reckitt Benckiser Group Stock Performance

Shares of Reckitt Benckiser Group stock traded down $0.05 during trading hours on Friday, hitting $15.42. The company's stock had a trading volume of 163,499 shares, compared to its average volume of 351,816. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.56 and a quick ratio of 0.37. Reckitt Benckiser Group has a 12-month low of $11.73 and a 12-month high of $15.82. The business has a 50 day moving average price of $14.89 and a two-hundred day moving average price of $13.89.

Reckitt Benckiser Group Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Thursday, September 25th. Shareholders of record on Monday, August 11th will be given a dividend of $0.2106 per share. The ex-dividend date is Friday, August 8th. This represents a yield of 341.0%.

Analyst Ratings Changes

RBGLY has been the topic of several recent research reports. Royal Bank Of Canada restated an "outperform" rating on shares of Reckitt Benckiser Group in a research report on Friday, July 25th. Sanford C. Bernstein upgraded Reckitt Benckiser Group from a "hold" rating to a "strong-buy" rating in a research note on Thursday, June 5th. Three analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and one has issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of "Buy".

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.